This study is in progress, not accepting new patients
A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy
Summary
- Eligibility
- for males ages 4 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Perry Shieh
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Perry Shieh
HS Clinical Professor, Neurology, Medicine. Authored (or co-authored) 88 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pfizer
- Links
- To obtain contact information for a study center near you, click here.
- ID
- NCT03362502
- Phase
- Phase 1 Duchenne Muscular Dystrophy Research Study
- Study Type
- Interventional
- Participants
- About 23 people participating
- Last Updated